Latest Articles

  • The microbiome in celiac disease: Beyond diet-genetic interactions
    Jose U. Scher, MD
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 228-230; DOI: https://doi.org/10.3949/ccjm.83a.15123

    Evidence points to the mix of bacteria that make the gut their home, collectively called the microbiome.

  • Reviewers 2015
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 231;
  • Interpreting SPRINT: How low should you go?
    George Thomas, MD, FACP, FASN, Joseph V. Nally, MD and Marc A. Pohl, MD
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 187-195; DOI: https://doi.org/10.3949/ccjm.83a.15175

    In treating hypertension, lower systolic pressure is better than higher—but with caveats.

  • It is not the critic’s voice that should count
    Kevin C. Giordano, ESQ
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 174-176; DOI: https://doi.org/10.3949/ccjm.83a.15105

    Lawsuits often confront physicians with incidental imperfections in the care they provided or with errors in their documentation.

  • Managing patients at genetic risk of breast cancer
    Holly J. Pederson, MD, Shilpa A. Padia, MD, Maureen May, CGC and Stephen Grobmyer, MD
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 199-206; DOI: https://doi.org/10.3949/ccjm.83a.14057

    People with these syndromes have a much higher risk, and the cancers often occur at an early age.

  • In reply: The PARADIGM-HF trial (October 2015)
    Marwa A. Sabe, MD, MPH, Miriam S. Jacob, MD and David O. Taylor, MD
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 167-168; DOI: https://doi.org/10.3949/ccjm.83c.03002
  • Advances in the treatment of dyslipidemia
    Marc S. Sabatine, MD, MPH
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 181-186; DOI: https://doi.org/10.3949/ccjm.83gr.16001

    Current guidelines do not set specifi c targets for LDL-C, but evidence supports the concept that lower is better.

  • Celiac disease: Managing a multisystem disorder
    Celiac disease: Managing a multisystem disorder
    Gursimran Singh Kochhar, MD, CNSC, FACP, Tavankit Singh, MD, Anant Gill, MBBS and Donald F. Kirby, MD, FACP, FACN, FACG, AGAF, CNSC, CPNS
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 217-227; DOI: https://doi.org/10.3949/ccjm.83a.14158

    This autoimmune disorder can cause symptoms that involve not only the gastrointestinal tract but also the skin and bones.

  • Can patients with infectious endocarditis be safely anticoagulated?
    Mandeep Singh Randhawa, MD, James Pile, MD and Marcelo Gomes, MD
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 169-171; DOI: https://doi.org/10.3949/ccjm.83a.15027

    New infectious endocarditis is not an indication for starting anticoagulation, and whether to continue it is a diffi cult decision.

  • Blood pressure management in the wake of SPRINT
    Edward J. Filippone, MD, FACP and Andrew J. Foy, MD
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 196-198; DOI: https://doi.org/10.3949/ccjm.83a.16015

    SPRINT should be interpreted in the context of prior trials and of its inclusion and exclusion criteria.

Pages